CHIRICO, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 879
EU - Europa 721
AS - Asia 260
OC - Oceania 3
SA - Sud America 2
AF - Africa 1
Totale 1.866
Nazione #
US - Stati Uniti d'America 877
IE - Irlanda 214
SE - Svezia 202
CN - Cina 151
IT - Italia 118
SG - Singapore 79
PL - Polonia 42
FI - Finlandia 37
DE - Germania 36
BE - Belgio 21
GB - Regno Unito 20
UA - Ucraina 15
IN - India 14
TR - Turchia 9
FR - Francia 8
VN - Vietnam 4
AU - Australia 3
AT - Austria 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
CA - Canada 1
HK - Hong Kong 1
ID - Indonesia 1
IM - Isola di Man 1
IR - Iran 1
LV - Lettonia 1
PR - Porto Rico 1
RU - Federazione Russa 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.866
Città #
Dublin 214
Chandler 213
Nyköping 113
Messina 77
Ashburn 64
Singapore 63
Ann Arbor 59
Beijing 54
Jacksonville 53
Warsaw 42
Dearborn 41
Houston 41
New York 36
Medford 33
Princeton 33
Cambridge 31
Des Moines 22
Brussels 21
Boardman 17
Munich 16
Jinan 15
Lancaster 12
Wilmington 12
San Mateo 11
Seattle 11
Bremen 9
Nanjing 9
Hangzhou 8
Pune 8
Zhengzhou 7
Hebei 6
Helsinki 6
Los Angeles 6
Nanchang 6
Shenyang 6
Woodbridge 6
Tianjin 5
Changsha 4
Dong Ket 4
Guangzhou 4
Hyderabad 4
Lanzhou 4
Milan 4
Torino 4
Fuzhou 3
Istanbul 3
Jiaxing 3
Melbourne 3
Ningbo 3
Shanghai 3
Washington 3
Fairfield 2
Mascali 2
Norwalk 2
Palermo 2
Ravenna 2
Rome 2
Rosignano Marittimo 2
Strasbourg 2
Vienna 2
Auburn Hills 1
Avcilar 1
Boston 1
Bratislava 1
Brno 1
Catania 1
Central 1
Changzhou 1
Chicago 1
Corigliano Calabro 1
Douglas 1
Edinburgh 1
Haikou 1
Irving 1
Jakarta 1
Kiev 1
London 1
Olomouc 1
Paris 1
Philadelphia 1
Rende 1
Riga 1
Sabz 1
San Juan 1
Taizhou 1
Tappahannock 1
Tomsk 1
Toronto 1
Wuhan 1
Yicheng 1
Totale 1.483
Nome #
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 109
Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications. 103
Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection. 85
Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation 82
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 81
High mobility group box 1 and tumor growth factor β: useful biomarkers in pediatric patients receiving peritoneal dialysis 77
The Role of Visfatin in Pregnancy, Complications and Procreation 70
Thalassaemia major and infectious risk: High Mobility Group Box-1 represents a novel diagnostic and prognostic biomarker 64
Idiopathic intracranial hypertension: a unifying neuroendocrine hypothesis through the adrenal-brain axis 62
Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: Serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment 61
Pseudotumor cerebri e Papilledema Idiopatico: un'analisi retrospettiva di tre centri pediatrici italiani. 60
High-mobility group protein B1 (HMGB1): a new biomarker of metabolic syndrome in obese children 59
"Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. 59
Pseudotumor cerebri syndrome and renal diseases in the pediatric population 59
From chronic kidney disease to transplantation: the roles of obestatin. 56
High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children 55
Fabry disease and kidney involvement: starting from childhood to understand the future 53
High-mobility group box 1 in allergic and non allergic upper airway inflammation 51
Vitamin D intoxication in two brothers: be careful with dietary supplements. 50
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Endothelial Progenitor Cells (EPCs) Evaluation in Aortic Aneurysm Repair. 47
Nonalcoholic Fatty Liver Disease/non-alcoholic steatohepatitis in childhood: Endocrine-metabolic "mal-programming" 45
Obestatin: a new element for mineral metabolism and inflammation in patients on hemodialysis. 44
Obestatin: an interesting but controversial gut hormone. 43
  Hypoprolactinemia in obese children: a bridge between inflammation and metabolic-endocrine dysfunction 43
Is there a risk of pubertal worsening in primary intestinal lymphangiectasia? 43
NGAL as an early biomarker of kidney disease in Joubert syndrome: three brothers compared. 42
High-Mobility Group Box 1 (HMGB1) in the childhood: latest findings and future prospects 42
HMGB-1 and TGFβ-1 highlight immuno-inflammatory and fibrotic processes before proteinuria onset in pediatric patients with Alport syndrome 39
Pediatric idiopathic intracranial hypertension and the underlying endocrine-metabolic dysfunction: a pilot study 38
CO(2) pneumoperitoneum induces in vitro hypoxic response culminating in apoptosis of human neuroblastoma cells 38
New available biomarkers to face a worldwide emergency: The childhood obesity 36
null 35
LMNA gene mutation as a model of cardiometabolic dysfunction: From genetic analysis to treatment response. 28
Thyroid dysfunction in thalassaemic patients: ferritin as a prognostic marker and combined iron chelators as an ideal therapy 27
null 23
Kawa-COVID-19 14
Acute Kidney Injury in Neonatal Intensive Care Unit: Epidemiology, Diagnosis and Risk Factors 5
Totale 1.928
Categoria #
all - tutte 8.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020194 0 0 0 0 4 51 19 22 20 41 25 12
2020/2021243 15 6 67 10 37 13 13 7 22 38 6 9
2021/2022276 3 20 5 16 12 6 23 21 2 64 25 79
2022/2023678 52 76 35 56 49 78 3 40 263 6 9 11
2023/2024209 11 24 11 30 21 56 7 14 3 5 0 27
2024/2025133 11 9 20 72 21 0 0 0 0 0 0 0
Totale 1.928